Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 6, 2024
Laparoscopic polyglycolic acid spacer placement for locally recurrent rectal cancerToshinori Kobayashi, Mitsugu Sekimoto, Hisanori Miki, et al.Acta Neuropathologica Communications|September 6, 2022
Discrepancy between distribution of alpha-synuclein oligomers and Lewy-related pathology in Parkinson's diseaseHiroaki Sekiya, Asato Tsuji, Yuki Hashimoto, et al.The Journal of Investigative Dermatology|February 20, 2021
Development of hMC1R Selective Small Agonists for Sunless Tanning and Prevention of Genotoxicity of UV in MelanocytesLeonid Koikov, Renny J Starner, Viki B Swope, et al.Dementia and Geriatric Cognitive Disorders|July 26, 2008
Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's diseaseMiyako Taniguchi, Yuka Okayama, Yuki Hashimoto, et al.Yonago Acta Medica|February 20, 2026
Longitudinal Dynamics of Soluble NKG2D Ligands in Mild and Moderate Coronavirus Disease-2019Kyosuke Nagamizu, Yukari Nishikawa, Miyako Takata, et al.Allergology International : Official Journal of the Japanese Society of Allergology|September 13, 2021
Association between the severity of chronic spontaneous urticaria and sleep-disordered breathingKisako Nagayama, Kentaro Watai, Kiyoshi Sekiya, et al.Biochemistry and Biophysics Reports|November 2, 2017
Alleviation of lipopolysaccharide/d-galactosamine-induced liver injury in leukocyte cell-derived chemotaxin 2 deficient miceAkinori Okumura, Takeshi Saito, Minoru Tobiume, et al.Scientific Reports|June 20, 2024
Prognostic scoring system based on indicators reflecting the tumor glandular differentiation and microenvironment for patients with colorectal cancerToshinori Kobayashi, Mitsuaki Ishida, Hisanori Miki, et al.FEBS Letters|January 29, 2013
Leukocyte cell-derived chemotaxin 2 is a zinc-binding proteinAkinori Okumura, Takehiro Suzuki, Hideyuki Miyatake, et al.European Journal of Pharmacology|December 5, 2006
Effects of TS-022, a newly developed prostanoid DP1 receptor agonist, on experimental pruritus, cutaneous barrier disruptions and atopic dermatitis in miceIwao Arai, Akiko Takaoka, Yuki Hashimoto, et al.Pageof 17